The antibody-drug conjugate trastuzumab deruxtecan (T-DXd; Enhertu) significantly improved progression-free survival (PFS) versus chemotherapy in previously treated ...
At Baylor Scott & White Health, a groundbreaking initiative is underway aiming to revolutionize early detection and intervention strategies for better breast cancer survivorship and beyond. Led by ...
Dr. Dempsey discusses how CDK4/6 Inhibitors have impacted medication costs for breast cancer care, and the importance of implementing cost containment strategies to alleviate the situation. Dr.
Results from the monarchE trial are analyzed by Hope Rugo, MD, and Joyce O'Shaughnessy, MD. Abemaciclib is recommended by NCCN in this setting based on the monarchE trial, which recently released its ...
Breast cancer patients who paused their endocrine therapy to try to get pregnant experienced short-term breast cancer recurrence rates similar to women who did not pause therapy for pregnancy, and ...
Renowned breast oncologist and clinical researcher to lead ongoing efforts to accelerate diagnostic discoveries and enable precision oncology through real-world evidence-based study platform Dr.
At Baylor Scott & White Health, a groundbreaking initiative is underway aiming to revolutionize early detection and intervention strategies for better breast cancer survivorship and beyond. Led by ...
Closely aligned with TCII is the TRIM-EBC Trial (Tirzepatide weight loss in patients with MRD and Early Breast Cancer), supported by a generous grant from the Mary Kay Ash Foundation ®. Through this ...
NORTHAMPTON, MA / ACCESS Newswire / February 4, 2026 / Originally published on newsroom.marykay.com At Baylor Scott & White Health, a groundbreaking initiative is underway aiming to revolutionize ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results